This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
EAU 2018
EAU 2018
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis and Penile Cancer
Endourology
Press
EAU 2018 Bladder Cancer
Viewing 41-60 of 64 articles
EAU 2018: Low Dose Gemcitabine Increases the Cytotoxicity of Human γδT Cell in In Vitro and in an Orthotopic Xenograft Model in Bladder Cancer
EAU 2018: Influence of Diabetes on the Risk of Urothelial Cancer According to Body Mass Index: A 10-Year Nationwide Population-Based Observational Study
EAU 2018: Pre-Operative Assessment in Elderly Bladder Cancer Patients
EAU 2018: The Best Local Palliative Treatment for Inoperable Bladder Cancer Patients
EAU 2018: The Role of Lymphadenectomy in Urological Cancers – Urothelial Cancer
EAU 2018: Early Surgical Safety Outcomes from PURE-01: Neoadjuvant Pembrolizumab before Radical Cystectomy For Muscle-Invasive Urothelial Bladder Carcinoma
EAU 2018: Nomogram-Based Risk Prediction of Local and Distant Relapse After Radical Cystectomy and the Role of Perioperative Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Multicenter Study
EAU 2018: Case-based Debate: How to Treat Multi-focal Ta, HG Disease if BCG is Unavailable?
EAU 2018: mpMRI in Bladder Cancer: Development of VI-RADS ver 1.0
EAU 2018: Impact of molecular sub types in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
EAU 2018: Bladder Cancer: Immediate and Late Complications of Robotic Cystectomy
EAU 2018: How Should I Treat a Patient with Initial T1HG Disease and No Tumour on Re-TUR?
EAU 2018: Next Steps for a Molecularly Classified Tumour
EAU 2018: Marker-Driven Use of NAC In (T2) Urothelial Cancer in an Otherwise Healthy Patient?
EAU 2018: Bladder Cancer: Immediate and Late Complications - Transurethral Resection of Bladder Tumor
EAU 2018: Bladder Cancer: Immediate and Late Complications Open Radical Cystectomy
EAU 2018: How Should I Manage a Patient with Tumour Recurrence Despite Adequate BCG?
EAU 2018: Oncologic Outcomes After Robot-Assisted Radical Cystectomy
EAU 2018: Functional Outcomes after Robot-Assisted Radical Cystectomy
EAU 2018: Emerging Biomarkers for Bladder Cancer Prognostication
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free